| The histone deacetylase inhibitor entinostat (SNDX-275) induces apoptosis in Hodgkin lymphoma cells and synergizes with Bcl-2 family inhibitors Á Jóna, N Khaskhely, D Buglio, JA Shafer, E Derenzini, CM Bollard, ... Experimental hematology 39 (10), 1007-1017. e1, 2011 | 64 | 2011 |
| Novel treatment strategies for patients with relapsed classical Hodgkin lymphoma A Jona, A Younes Blood reviews 24 (6), 233-238, 2010 | 50 | 2010 |
| Immunologic pathomechanism of Hodgkin's lymphoma A Jona, P Szodoray, A Illés Experimental Hematology 41 (12), 995-1004, 2013 | 28 | 2013 |
| Effect of bleomycin hydrolase gene polymorphism on late pulmonary complications of treatment for Hodgkin lymphoma Á Jóna, Z Miltényi, S Póliska, BL Bálint, Á Illés PLoS One 11 (6), e0157651, 2016 | 27 | 2016 |
| Brentuximab vedotin for treating Hodgkin’s lymphoma: an analysis of pharmacology and clinical efficacy Á Illés, Á Jóna, Z Miltényi Expert opinion on drug metabolism & toxicology 11 (3), 451-459, 2015 | 22 | 2015 |
| Late pulmonary complications of treating Hodgkin lymphoma: bleomycin-induced toxicity Á Jóna, Z Miltényi, Z Ujj, I Garai, M Szilasi, Á Illés Expert Opinion on Drug Safety 13 (10), 1291-1297, 2014 | 19 | 2014 |
| Combined prognostic value of absolute lymphocyte/monocyte ratio in peripheral blood and interim PET/CT results in Hodgkin lymphoma Z Simon, S Barna, Z Miltenyi, K Husi, F Magyari, A Jona, I Garai, Z Nagy, ... International journal of hematology 103, 63-69, 2016 | 18 | 2016 |
| The pan-deacetylase inhibitor panobinostat downregulates HIF-1α and VEGF and, synergizes with everolimus in Hodgkin lymphoma cell lines M Lemoine, D Buglio, A Jona, E Derenzini, LJ Medeiros, DA Berry, ... Blood, The Journal of the American Society of Hematology 116 (21), 2851-2851, 2010 | 11 | 2010 |
| Hypoxia‐related carbonic anhydrase IX expression is associated with unfavourable response to first‐line therapy in classical Hodgkin's lymphoma G Méhes, O Matolay, L Beke, M Czenke, Á Jóna, Z Miltényi, Á Illés, ... Histopathology 74 (5), 699-708, 2019 | 9 | 2019 |
| Prognostic value of interim and restaging PET/CT in Hodgkin lymphoma. Results of the CHEAP (chemotherapy effectiveness assessment by PET/CT) study—long term observation Z Miltenyi, S Barna, I Garai, Z Simon, A Jona, F Magyari, M Gergely, ... Neoplasma 62 (4), 627-634, 2015 | 8 | 2015 |
| Changing patterns in the clinical pathological features of hodgkin lymphoma: a report from debrecen, hungary Z Miltényi, Z Simon, E Páyer, L Váróczy, L Gergely, Á Jóna, Á Illés International Scholarly Research Notices 2011, 2011 | 8 | 2011 |
| Diagnostic difficulties caused by a pulmonary infiltrate Z Simon, Á Jóna, Z Miltényi, E Páyer, A Lieber, M Szilasi, Á Illés Orvosi hetilap 153 (27), 1077-1081, 2012 | 6 | 2012 |
| Pulmonary alterations in Hodgkin lymphoma Á Jóna, Á Illés, K Szemes, Z Miltényi Orvosi Hetilap 157 (5), 163-173, 2016 | 5 | 2016 |
| Clinical and biological prognostic factors in follicular lymphoma patients Á Jóna, A Kenyeres, S Barna, Á Illés, Z Simon Plos one 17 (8), e0272787, 2022 | 4 | 2022 |
| How the epidemiology of Hodgkin lymphoma changed in Debrecen, Hungary L Pinczés, Z Miltényi, Á Jóna, F Magyari, Á Illés Medical Research Archives 4 (6), 2016 | 4 | 2016 |
| The histone deacetylase inhibitor entinostat (SNDX-275) targets Hodgkin lymphoma through a dual mechanism of immune modulation and apoptosis induction A Jona, N Khaskhely, D Buglio, JA Shafer, E Derenzini, CM Bollard, ... Blood 116 (21), 2850, 2010 | 4 | 2010 |
| Parallel testing of liquid biopsy (ctDNA) and tissue biopsy samples reveals a higher frequency of EZH2 mutations in follicular lymphoma Á Nagy, B Bátai, L Kiss, S Gróf, PA Király, Á Jóna, J Demeter, H Sánta, ... Journal of Internal Medicine 294 (3), 295-313, 2023 | 2 | 2023 |
| Pulmonary Toxicity of Hodgkin Lymphoma Treatment: A Prospective Single-Center Study A Jona, Z Miltenyi, L Pinczes, P Kerek, N Bittner, M Szilasi, S Barna, ... Journal of Hematology 10 (6), 266, 2021 | 2 | 2021 |
| Treatment of relapsed Hodgkin lymphoma after autologous stem cell Transplantation Á Illés, Z Simon, M Udvardy, F Magyari, Á Jóna, Z Miltényi Orvosi Hetilap 158 (34), 1338-1345, 2017 | 2 | 2017 |
| Rapidly progressing refractory Hodgkin lymphoma: a case report and a possible explanation Á Jóna, G Irsai, S Barna, G Méhes, Á Illés, L Váróczy Case Reports in Medicine 2016, 2016 | 2 | 2016 |
Dr. Miltényi ZsófiaDE ÁOK Belgyógyászati IntézetVerified email at belklinika.com
